Which pharmaceutical company underwent a major rebranding in 2019 that included dropping its corporate logo from drug packaging to focus more on disease awareness and patient education?

The healthcare and pharmaceutical industry has seen significant shifts in how companies build and maintain their brand identities. As medical products become increasingly specialized and consumer engagement grows more important, pharmaceutical companies have had to adapt their branding strategies. This poll tests your knowledge about a notable pharmaceutical rebranding effort that significantly impacted market perception and patient engagement in recent years.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Pfizer - implementing their 'Science Will Win' campaign while minimizing corporate branding on medications
Novartis - adopting a 'patient journey' approach that prioritized condition information over company logos on packaging
Merck - launching their 'Beyond the Pill' initiative that removed corporate identifiers from prescription medications
GlaxoSmithKline - introducing transparent labeling that emphasized active ingredients rather than brand identity